These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3811645

  • 21. Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.
    Ciancioni C, Poignet JL, Mauras Y, Panthier G, Delons S, Allain P, Man NK.
    Trans Am Soc Artif Intern Organs; 1984; 30():479-82. PubMed ID: 6533925
    [No Abstract] [Full Text] [Related]

  • 22. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 23. [The effect of desferrioxamine in aluminum-processing workers].
    Hosovski E, Vidaković A.
    Srp Arh Celok Lek; 1990; 118(9-10):341-5. PubMed ID: 2102549
    [Abstract] [Full Text] [Related]

  • 24. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM.
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [Abstract] [Full Text] [Related]

  • 25. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG, Acuña Aguerre G, Fernández Martín JL, Mouzo R, Cannata Andía JB.
    Nephrol Dial Transplant; 1994 Oct; 9(10):1431-4. PubMed ID: 7816256
    [Abstract] [Full Text] [Related]

  • 26. Desferrioxamine treatment for aluminium and iron overload in uraemic patients by haemodialysis or haemofiltration.
    Baldamus CA, Schmidt H, Scheuermann EH, Werner E, Kaltwasser JP, Schoeppe W.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Oct; 21():382-6. PubMed ID: 3991527
    [Abstract] [Full Text] [Related]

  • 27. Clinical and histological results of long-term management of aluminium overloading in uraemic patients with desferrioxamine.
    Canavese C, Pacitti A, Segoloni G, Thea A, D'Amicone M, Stratta P, Rossi P, Sabbioni E, Pietra R, Constantini S.
    J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):17-23. PubMed ID: 2535315
    [Abstract] [Full Text] [Related]

  • 28. [Speech apraxia in dialysis-associated aluminum encephalopathy].
    Haug BA, Botsch G, Felgenhauer K.
    Nervenarzt; 1991 Oct; 62(10):637-40. PubMed ID: 1749454
    [Abstract] [Full Text] [Related]

  • 29. Alteration of trace element distribution and testis ACE activity in mice with high peritoneal aluminum.
    Guo CH, Huang CJ, Chiou YL, Hsu GS.
    Biol Trace Elem Res; 2002 May; 86(2):145-57. PubMed ID: 12008977
    [Abstract] [Full Text] [Related]

  • 30. Trace element levels in adult patients with proteinuria.
    Bovio G, Piazza V, Ronchi A, Montagna G, Semeraro L, Galli F, Efficace E, Picardi L, Villa G, Segagni S, Minoia C.
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):329-36. PubMed ID: 18043551
    [Abstract] [Full Text] [Related]

  • 31. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, Di Giulio S, Drüeke T.
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [Abstract] [Full Text] [Related]

  • 32. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H, Stummvoll HK, Kovarik J, Meisinger V, Wolf A, Pinggera WF.
    Wien Klin Wochenschr; 1980 Jun; 92(11):391-4. PubMed ID: 7424016
    [Abstract] [Full Text] [Related]

  • 33. Haemofiltration or haemodialysis in aluminium elimination?
    Sulkova S, Laurincova Z, Válek A.
    Nephrol Dial Transplant; 1991 Jun; 6 Suppl 3():3-5. PubMed ID: 1775263
    [Abstract] [Full Text] [Related]

  • 34. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.
    G Ital Nefrol; 2002 Jun; 19(5):552-9. PubMed ID: 12439845
    [Abstract] [Full Text] [Related]

  • 35. Hyperaluminemia associated with liver transplantation and acute renal failure.
    Erasmus RT, Kusnir J, Stevenson WC, Lobo P, Herman MM, Wills MR, Savory J.
    Clin Transplant; 1995 Aug; 9(4):307-11. PubMed ID: 7579738
    [Abstract] [Full Text] [Related]

  • 36. Prevention and treatment of aluminum overload in uremic patients: long-term results.
    Canavese C, Thea A, Pacitti A, Salomone M, Mangiarotti G, Segoloni G, Stratta P, Gurioli L, Constantini S, Giordini R.
    Clin Nephrol; 1989 Apr; 31(4):169-74. PubMed ID: 2714022
    [Abstract] [Full Text] [Related]

  • 37. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 38. Effects of oral aluminum on essential trace elements metabolism during pregnancy.
    Bellés M, Albina ML, Sanchez DJ, Corbella J, Domingo JL.
    Biol Trace Elem Res; 2001 Jan; 79(1):67-81. PubMed ID: 11318238
    [Abstract] [Full Text] [Related]

  • 39. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
    Yokel RA, Ackrill P, Burgess E, Day JP, Domingo JL, Flaten TP, Savory J.
    J Toxicol Environ Health; 1996 Aug 30; 48(6):667-83. PubMed ID: 8772805
    [Abstract] [Full Text] [Related]

  • 40. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ, Sharf B, Bell P, Meyers AM.
    Clin Nephrol; 1983 Oct 30; 20(4):202-7. PubMed ID: 6641027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.